Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Intestinal Failure in Necrotising Enterocolitis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2013 by Maastricht University Medical Center.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Maastricht University Medical Center Identifier:
First received: September 21, 2011
Last updated: December 17, 2013
Last verified: December 2013

Necrotizing enterocolitis (NEC) is a severe gastrointestinal disorder with high morbidity and mortality (20-40%), affecting predominantly premature neonates. NEC continues to present a diagnostic challenge to clinicians. The initial clinical manifestations of NEC are non-specific and indistinguishable from other gastrointestinal disorders and sepsis.

The first goal of this study is to find and evaluate tests to diagnose NEC at an early stage. For the development of new diagnostic markers, the investigators require knowledge of pathophysiological processes that underlie NEC, which still remain unclear. Therefore, the second goal of this study is to elucidate the etiology of NEC. Furthermore, understanding of the pathophysiology of NEC can offer the possibility to develop new therapeutical treatments.

Necrotizing Enterocolitis

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Intestinal Failure in Necrotising Enterocolitis

Resource links provided by NLM:

Further study details as provided by Maastricht University Medical Center:

Primary Outcome Measures:
  • Urinary I-FABP [ Time Frame: Within the first 30 days (plus or minus 3 days) after clinical suspicion of NEC ] [ Designated as safety issue: No ]

Estimated Enrollment: 300
Study Start Date: September 2004
Estimated Study Completion Date: September 2016
Estimated Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)
NEC suspected - Final diagnosis NEC
NEC suspected - Final diagnosis no NEC


Ages Eligible for Study:   Child, Adult, Senior
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Neonates with abdominal signs suspected of NEC All neonates admitted to the NICU of the Maastricht University Medical Center between July 2007 and July 2008

Inclusion Criteria:

  • Neonates with abdominal signs suspected of NEC
  • All neonates admitted to the NICU of the Maastricht University Medical Center between July 2007 and July 2008

Exclusion Criteria:

  • No written informed consent of both parents
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01441739

Contact: Kostan Reisinger, MD +31433882125

Maastricht University Medical Center Recruiting
Maastricht, Netherlands, 6229 HX
Contact: Kostan Reisinger, MD    +31433882125   
University Medical Center Utrecht Recruiting
Utrecht, Netherlands, 3584 CX
Contact: Hens Brouwers, MD, PhD    +31887554545   
Sponsors and Collaborators
Maastricht University Medical Center
  More Information

Responsible Party: Maastricht University Medical Center Identifier: NCT01441739     History of Changes
Other Study ID Numbers: MEC 04-197 
Study First Received: September 21, 2011
Last Updated: December 17, 2013
Health Authority: Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)

Additional relevant MeSH terms:
Enterocolitis, Necrotizing
Gastrointestinal Diseases
Digestive System Diseases
Intestinal Diseases processed this record on September 28, 2016